德罗佩里多尔加二胺用于疑似大麻素过度复杂综合征的症状改善:一项前性队列研究
Quincy Chopra1, Vincent Peyko2, Jessica Annie Lee3
1Department of Emergency Medicine, Palmdale Regional Medical Center, Palmdale, CA, USA.
Open access emergency medicine : OAEM
|December 2, 2024
概括
这项研究表明,多利多尔加二胺有效治疗大麻素过度复杂综合征 (CHS) 症状,如恶心和吐. 治疗显著降低了症状严重程度,并在一周内减少了急诊室的重复访问.
科学领域:
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 加拿大大麻素过度吸收综合征 (CHS) 在慢性大麻使用者中引起严重的恶心和吐.
- 目前对CHS的治疗选择有限,正在进行优化疗法的研究.
- 哈洛佩里多尔已经显示出对丹塞的优越性,而德罗佩里多尔是潜在的治疗选择.
研究的目的:
- 为了前性地评估德罗佩里多尔与二胺结合在缓解急性CHS症状中的有效性.
- 评估这种联合治疗对恶心,吐和腹部不适的影响.
- 为了确定治疗后七天内急诊室 (ED) 复诊率.
主要方法:
- 在急诊室 (ED) 进行了一项多中心的前性干预研究.
- 参与者接受了治疗急性CHS的多佩里多尔和迪芬胺的治疗方案.
- 视觉模拟尺度 (VAS) 对恶心,吐和腹痛的得分被测量了长达120分钟;ED重复访问被跟踪了七天.
主要成果:
- 这项研究包括47名接受droperidol的参与者.
- 恶心和吐的VAS得分与治疗后30分钟和120分钟的基线显著下降 (p <0.05).
- 腹部疼痛VAS得分也显示在30分钟和120分钟显著减少 (p <0.05),在7天内返回ED的比例为12.9%.
结论:
- 滴滴醇和迪芬胺的组合显著改善了CHS症状,包括恶心,吐和腹痛.
- 研究方案显示,在服用后30分钟和120分钟,症状严重程度有所降低.
- 在一周内返回ED的低率表明这种治疗方法对急性CHS的疗效.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
201
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
201
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
224
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
224
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163


